… (VITT) was reported in the letter-to-editor submission in the journal of Indian Journal of … 04th Mar 2022 has been titled as firstreport of VITT from India which is a very conflicting statistic. …
S Guditi, G Setty, M Verma, R Reddy, R Devraj… - Transplantation …, 2022 - Elsevier
… the firstreport of thromboticthrombocytopenic … report successful organ donation from a case of VITT following the COVID-19 vaccination with AstraZeneca Oxford (Serum Institute of India…
C John, R Kumar, AK Sivan, S Jithin, R Abraham… - 2021 - europepmc.org
… Vaccineinducedthromboticthrombocytopenia ( VITT) is a rare but … reportVITT for the first time from India in two previously healthy young men who presented with thrombocytopenia…
TE Warkentin, A Cuker - Update May, 2021 - medilib.ir
… Earlyreports in which patients were treated with heparins described clinical worsening, … of Oxford, and Serum Institute of India) vaccine and have not developed VITT, there are no good …
C Rodríguez, A Pérez-Nieva, L Máiz… - Thrombosis …, 2021 - ncbi.nlm.nih.gov
… We present a case report of an individual who developed VITT 5 days after administration of the BNT162b2 Covid-19 vaccine (Pfizer-BioNTech), a lipid nanoparticle–formulated, …
M Sarkar, IV Madabhavi, PN Quy… - Annals of Thoracic …, 2022 - journals.lww.com
… AstraZeneca, University of Oxford, and Serum Institute of India) or the Ad26.COV2.S vaccine … , however, we will use the term VITT, given the temporal relationship of disease with COVID-…
K Mishra, S Barki, S Pattanayak, M Shyam… - Indian Journal of …, 2021 - Springer
… and history of vaccination, and thrombocytopenia, clinical diagnosis of vaccine-induced … case of VITT in India [5]. Therefore, the index case may be the first case of VITT from India. …
A Sunder, S Saha, S Kamath… - Journal of Family …, 2022 - journals.lww.com
… 19 (AstraZeneca University of Oxford and Serum Institute of India). This has been termed as … Rivaroxaban after thrombocytopenia is corrected. Herewith, we report a case of VITT who …